Minimizing the Immune Response: Overcoming the Hurdles to Successful AAV Gene Therapies
Time: 11:00 am
day: Immunogenicity Discussion Day
Details:
- Understanding the complex mixture of innate, humoral and cellular immunogenicity concerns with AAV
- Exploring the state of play between ‘one and done’ and redosing strategies
- Combatting high dose AAV toxicities with new strategies